References
- Matsuda R, Takahashi T, Nakamura S, et al : Expression of the c-kit protein in human solid tumors and in corresponding fetal and adult normal tissues. Am J Pathoi. 1993 ; 142 : 339-346
- Lammie A, Drobnjak M, Gerald W, Saad A, Cote R, Cordon-Cardo C : Expression of c-kit and kit ligand proteins in normal human tissues. J Histochem Cytochem. 1994 ; 42 : 1417-1425 https://doi.org/10.1177/42.11.7523489
- Lasota J, Jasinski M, Sarlomo-Rikala M, Miettinen M : Mutations in exon 11 of c-kit occur preferentially in malignantversus benign gastrointestinal tumors and do not occur in leiomyomas or leiomyosarcomas. Am J Pathol. 1999 ; 154 : 53-60 https://doi.org/10.1016/S0002-9440(10)65250-9
- Arber DA, Tamayo R, Weiss LM : Paraffin section detection of the c-kit gene product(CD117) in humantissues: value in the diagnosis of mast cell disorders. Hum Pathol. 1998 ; 29 : 498-504 https://doi.org/10.1016/S0046-8177(98)90066-1
- Sawyers CL : Rational therapeutic intervention in cancer : kinases as drug targets. Curr Opinions Gene Dev. 2002 ; 12 : 111-115 https://doi.org/10.1016/S0959-437X(01)00273-8
- Holst VA, Marshall CE, Moskaluk CA, Frierson HF Jr : KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol. 1999 ; 12 : 956-960
- Jeng YM, Lin CY, Hsu HC : Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma. Cancer Lett. 2000 ; 154 : 107-111 https://doi.org/10.1016/S0304-3835(00)00387-6
- Penner CR, Folpe AL, Budnick SD : C-kit expression distinguishes salivary gland adenoid cystic carcinoma from polymorphous low-grade adenocarcinoma. Mod Pathol. 2002 ; 15 : 687-691 https://doi.org/10.1097/01.MP.0000018973.17736.F8
- Edwards PC, Bhuiya T, Kelsch RD : C-kit expression in the salivaryglandneoplasmadenoidcysticcarcinoma, polymorphous low-grade adenocarcinoma, and monomorphic adenoma. Oral Surg Oral Med Oral Pathol: 2003 ; 95 : 586-593 https://doi.org/10.1067/moe.2003.31
- Smithey BE, Pappo AS, Hill DA : C-kit expression in pediatric solid tumors : a comparative immunohistochemical study. Am J Surg Pathol. 2002 ; 26 : 486-492 https://doi.org/10.1097/00000478-200204000-00011
- Scotlandi K, Manara MC, Strammiello R, et al : C-kit receptor expression in Ewing's sarcoma : lack of prognostic value but therapeutic targeting opportunities in appropriate conditions. J Clin Oncol. 2003 ; 15 : 1952-1960
- Lu CS, Kashima K, Daa T, Yokoyama S, Yanagisawa S, Nakayama I : Immunohistochemical study of the distribution of endogenous biotin and biotin-bindingenzymes in ductal structures of salivary gland tumours. J Oral Pathol Med. 2000 ; 29 : 445-451 https://doi.org/10.1034/j.1600-0714.2000.290905.x
- Bussilati G, Gugliotta P, Volante M, Pace M, Papotti M : Retrieved endogenous biotin : a novel marker and a potential pitfall in diagnostic immunohistochemistry. Histopothology. 1997 ; 31 :400-407 https://doi.org/10.1046/j.1365-2559.1997.3020895.x
- Dagher R, Cohen M, Williams G, et al : Approval summary : imatinib mesylate in the treatment of metastatic and/or unresectable malignant gastrointestinal stromal tumors. Clin Cancer Res. 2002 ; 8 : 3034-3038
- Chen H, Isozaki K, Kinoshita K, et al : lmatinib inhibits various types of activating mutant kit found in gastrointestinal stromal tumors. Int J Cancer. 2003 ; 105 : 130-135 https://doi.org/10.1002/ijc.11025
- Zennati Y, De Sepulveda P, Feger F, et al : Effect of tyrosine kinase inhibitor STI571 on the kinase activity of wild-type and various mutated c-kit receptors found in mast cell neoplasms. Oncogene. 2003 ; 22 : 660-664. https://doi.org/10.1038/sj.onc.1206120
- Bauer S, Corless CL, Heinrich MC, et al : Response to imatinib mesylate of a gastointestinal stromal tumor with very low expression of KIT. Cancer Chemother Pharmacol. 2003 ; 51 : 261-265